QR Kod

Clinical value of Alzheimer's disease biomarker testing

Abstract INTRODUCTION In the Investigating the Impact of Alzheimer's Disease Diagnostics in British Columbia (IMPACT‐AD BC) study, we aimed to understand how Alzheimer's disease (AD) cerebrospinal fluid (CSF) biomarker testing—used in medical care—impacted medical decision‐making (medical utility),...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Khushbu J. Patel, David Yang, John R. Best, Colleen Chambers, Philip E. Lee, Alexandre Henri‐Bhargava, Clark R. Funnell, Dean J. Foti, Jacqueline A. Pettersen, Howard H. Feldman, Haakon B. Nygaard, Ging‐Yuek R. Hsiung, Mari L. DeMarco
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wiley 2024-04-01
Seri Bilgileri:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Konular:
Alzheimer's disease
biomarkers
cerebrospinal fluid
clinical decision making
counseling
dementia
Online Erişim:https://doi.org/10.1002/trc2.12464
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller